Paper3929314
Tyramine pressor sensitivity changes during deprenyl treatment.
Sunderland T and 5 others. Psychopharmacology (Berl), 1985. Cited by 76 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tyramine pressor sensitivity changes during deprenyl treatment. Papers, record 3929314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3929314
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Pressure | Major topic |
| Phenethylamines | Major topic |
| Selegiline | Major topic |
| Tyramine | Major topic |
| Dose-Response Relationship, Drug | |
| Humans | |
| Methoxyhydroxyphenylglycol | |
| Monoamine Oxidase |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,207,877 | Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes. | Neuropharmacology | 1975 | https://conductscience.org/library/papers/1207877 | PubMed |
| 2 | 4,943,186 | Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. | Psychopharmacologia | 1970 | https://conductscience.org/library/papers/4943186 | PubMed |
| 3 | 49,518 | Intravenous tyramine pressor response in depression. | Lancet | 1975 | https://conductscience.org/library/papers/49518 | PubMed |
| 4 | 6,284,529 | Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat. | Eur J Pharmacol | 1982 | https://conductscience.org/library/papers/6284529 | PubMed |
| 5 | 111,274 | Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/111274 | PubMed |
| 6 | 14,163,106 | MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE. | JAMA | 1964 | https://conductscience.org/library/papers/14163106 | PubMed |
| 7 | 7,260,342 | Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. | Biomed Mass Spectrom | 1981 | https://conductscience.org/library/papers/7260342 | PubMed |
| 8 | 6,814,755 | (-)Deprenyl in the treatment of Parkinson's disease. | Clin Neuropharmacol | 1982 | https://conductscience.org/library/papers/6814755 | PubMed |
| 9 | 6,768,943 | L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression. | Life Sci | 1980 | https://conductscience.org/library/papers/6768943 | PubMed |
| 10 | 6,791,210 | Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6791210 | PubMed |
| 11 | 708,454 | Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/708454 | PubMed |
| 12 | 71,602 | Deprenyl in Parkinson's disease. | Lancet | 1977 | https://conductscience.org/library/papers/71602 | PubMed |
| 13 | 4,947,578 | Interactions of monoamine oxidase inhibitors, amines, and foodstuffs. | Adv Pharmacol Chemother | 1970 | https://conductscience.org/library/papers/4947578 | PubMed |
| 14 | 6,791,202 | Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6791202 | PubMed |
| 15 | 834,248 | Dopamine is a monoamine oxidase B substrate in man. | Nature | 1977 | https://conductscience.org/library/papers/834248 | PubMed |
| 16 | 745,013 | Absence of "cheese effect" during deprenyl therapy: some recent studies. | J Neural Transm | 1978 | https://conductscience.org/library/papers/745013 | PubMed |
| 17 | 6,056,555 | Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250"). | Acta Med Acad Sci Hung | 1967 | https://conductscience.org/library/papers/6056555 | PubMed |
| 18 | 6,785,797 | Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect? | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6785797 | PubMed |
| 19 | 656,120 | Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/656120 | PubMed |
| 20 | 495,801 | Tyramine infusions in bipolar illness: behavioral effects and longitudinal changes in pressor sensitivity. | Am J Psychiatry | 1979 | https://conductscience.org/library/papers/495801 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,574,581 | The role of monoamine oxidase A in the neurobiology of aggressive, antisocial, and violent behavior: A tale of mice and men. | Prog Neurobiol | 2020 | https://conductscience.org/library/papers/32574581 | PubMed |
| 25,249,059 | Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. | Neuropsychopharmacology | 2015 | https://conductscience.org/library/papers/25249059 | PubMed |
| 23,934,742 | Current place of monoamine oxidase inhibitors in the treatment of depression. | CNS Drugs | 2013 | https://conductscience.org/library/papers/23934742 | PubMed |
| 18,728,814 | Depression in Parkinson's disease: health risks, etiology, and treatment options. | Neuropsychiatr Dis Treat | 2008 | https://conductscience.org/library/papers/18728814 | PubMed |
| 18,311,418 | A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. | Prim Care Companion J Clin Psychiatry | 2008 | https://conductscience.org/library/papers/18311418 | PubMed |
| 10,050,962 | Screen for MAOA mutations in target human groups. | Am J Med Genet | 1999 | https://conductscience.org/library/papers/10050962 | PubMed |
| 9,673,855 | Safety of selegiline (deprenyl) in the treatment of Parkinson's disease. | Drug Saf | 1998 | https://conductscience.org/library/papers/9673855 | PubMed |
| 9,285,463 | Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1997 | https://conductscience.org/library/papers/9285463 | PubMed |
| 8,857,072 | Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline. | Eur J Clin Pharmacol | 1996 | https://conductscience.org/library/papers/8857072 | PubMed |
| 8,613,523 | Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8613523 | PubMed |
| 8,136,085 | Comparative tolerability profiles of the newer versus older antidepressants. | Drug Saf | 1994 | https://conductscience.org/library/papers/8136085 | PubMed |
| 3,145,523 | Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3145523 | PubMed |
| 3,114,792 | Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/3114792 | PubMed |
| 2,436,247 | Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/2436247 | PubMed |
| 1,794,016 | Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease. | Drugs Aging | 1991 | https://conductscience.org/library/papers/1794016 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAOA | 4,128 | PubTator's text mining | https://conductscience.org/library/genes/4128 | NCBI Gene |
| MAOB | 4,129 | PubTator's text mining | https://conductscience.org/library/genes/4129 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3929314
GET https://conductscience.org/api/papers/v1/3929314/references?page=2